Antiphospholipid Syndrome

This presentation explores antiphospholipid syndrome (APS) and the immune dysregulation that contributes to thrombosis and pregnancy complications. Alongside conventional diagnosis and anticoagulant management, it places particular emphasis on complementary immunomodulatory and regenerative approaches. These include Autologous Active Specific Immunotherapy (AASI®), precursor stem cell therapy, GcMAF Forte, thymus therapy, and Super Transfer Factor. The presentation discusses how these approaches aim to regulate abnormal immune activity, reduce harmful autoantibody responses, support T-cell and macrophage function, and promote tissue repair as part of an integrative management strategy.